CMS issues the first annual outside evaluation of the Next Generation ACO program, finding some modest savings.
Read More
A study carried in Health Affairs discusses trends in high-deductible health plans.
Read More
The Alliance for Regenerative Medicine releases a sponsored study of the cost-effectiveness analysis of new cell and gene therapies.
Read More
Hospitals post underwhelming purchasing savings following acquisition activity, according to a new paper at NBER.
Read More
An analysis published in JAMA finds that Medicare is wasting about a billion dollars a year purchasing brand-name drugs.
Read More
An analysis in Health Affairs compares hospital, home health and SNF use and variation in Medicare Advantage versus the fee-for-service version.
Read More
A report from the Minnesota Department of Health reveals the variation in hospital pricing.
Read More
McKinsey gives us its perspective on trends in Medicare Advantage star ratings.
Read More
The last in a long series about specialty drug trends, including a look forward.
Read More
Part 3 of a review of the EMD Serono Specialty Drug Digest, focusing on utilization and network management.
Read More
The latest edition of the EMD Serono is loaded with insights on specialty drug use and management.
Read More
The National Business Group on Health gives us a few tidbits from their latest survey of large employers on their health plan intentions.
Read More
An analysis in Health Affairs reviews trends in spending for persons eligible for both Medicare and Medicaid.
Read More
A Commonwealth Fund post shows just how concentrated our provider and health plan markets have become.
Read More